Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis.

Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis.

Item
http://www.wikidata.org/entity/Q45265574
In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate.Characterising lipid lipolysis and its implication in lipid-based formulation development.Evaluation of Pharmacokinetics, and Bioavailability of Higher Doses of Tocotrienols in Healthy Fed HumansEvaluation of a nanoemulsion formulation strategy for oral bioavailability enhancement of danazol in rats and dogs.The effect of oral lipids and circulating lipoproteins on the metabolism of drugs.New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage forms.A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development.SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization.Nonlinear absorption kinetics of self-emulsifying drug delivery systems (SEDDS) containing tocotrienols as lipophilic molecules: in vivo and in vitro studies.Effects of polysorbate 80 on the in-vitro precipitation and oral bioavailability of halofantrine from polyethylene glycol 400 formulations in rats.Optimization of self nanoemulsifying drug delivery system for poorly water-soluble drug using response surface methodology.Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats.In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systemsBioavailability of Cinnarizine in Dogs: Effect of SNEDDS Loading Level and Correlation with Cinnarizine Solubilization During In Vitro LipolysisDevelopment of Self-Emulsifying Drug Delivery Systems (SEDDS) for Oral Bioavailability Enhancement of Poorly Soluble DrugsEffect of bile on the oral absorption of halofantrine in polyethylene glycol 400 and polysorbate 80 formulations dosed to bile duct cannulated rats
P2860

Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis.

Item
http://www.wikidata.org/entity/Q45265574
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Lipid-based formulations for d ...... nd dynamic in vitro lipolysis.
@en
Lipid-based formulations for d ...... nd dynamic in vitro lipolysis.
@nl
type
label
Lipid-based formulations for d ...... nd dynamic in vitro lipolysis.
@en
Lipid-based formulations for d ...... nd dynamic in vitro lipolysis.
@nl
prefLabel
Lipid-based formulations for d ...... nd dynamic in vitro lipolysis.
@en
Lipid-based formulations for d ...... nd dynamic in vitro lipolysis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Lipid-based formulations for d ...... nd dynamic in vitro lipolysis.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698